High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2006.12.076 | DOI Listing |
Publication Analysis
Top Keywords
human ccr8
8
ccr8 antagonists
8
oxazolidinones novel
4
novel human
4
antagonists high-throughput
4
high-throughput screening
4
screening corporate
4
corporate compound
4
compound collection
4
collection led
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!